Ben is an Investment Director with GBS Venture Partners, a leading Australian life-science focused venture fund he joined in 2003. Ben has held board positions on a number of companies including acting as company secretary for an ASX listed entity and is currently on the boards of Hydrexia Pty Ltd, Coda Therapeutics Pty Ltd, and chair of the audit committee of Neuromonics Pty Ltd.
Prior to GBS, Ben spent several years in the legal industry practicing as a Solicitor and managing international litigation. Ben is admitted to the Victorian Supreme Court as a Barrister and Solicitor, earned his Bachelor of Law and Bachelor of Science degrees from Monash University in Melbourne and has a Graduate Diploma in Applied Finance and Investment.
Sep 02, 2014 Hatchtech Announces Successful Phase 3 Results
Dec 11, 2013 Hatchtech Receives SPA and Announces Patent Grants